Petition DENIED. Justice Jackson took no part in the consideration or decision of this petition. See 28 U. S. C. §455 and Code of Conduct for Justices of the Supreme Court of the United States, Canon 3B(2)(d)(ii) and 3B(2)(f)(i).

DISTRIBUTED for Conference of 9/30/2024.

Reply of petitioner United Therapeutics Corporation filed. (Distributed)

Brief of respondent Liquidia Technologies, Inc. in opposition filed.

Motion to extend the time to file a response is granted and the time is extended to and including August 28, 2024.

Motion to extend the time to file a response from August 12, 2024 to August 28, 2024, submitted to The Clerk.

Response Requested. (Due August 12, 2024)

DISTRIBUTED for Conference of 9/30/2024.

Waiver of right of respondent Liquidia Technologies, Inc. to respond filed.

Petition for a writ of certiorari filed. (Response due July 12, 2024)

United Therapeutics Corporation, Petitioner, represented by Douglas H Carsten

Liquidia Technologies, Inc., Respondent, represented by Kathleen Roberta Hartnett